Drug reference
inactivated poliomyelitis vaccine
Killed (Inactivated) viral vaccine · Vaccine for poliomyelitis
Killed (Inactivated) viral vaccineVaccine for poliomyelitis
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
It is an inactivated suspension of the poliovirus, which elicits an immune response without causing disease.
Indications
Primary immunization in adults (due to higher risk of paralysis with OPV)Immunization in persons with compromised immune system
Dosing
- Adult
- Three doses of 1 ml each injected s.c. in the deltoid region at 4–6 week intervals. A fourth dose is given 6–12 months later. Booster doses are given every 5 years.
- Geriatric
- Three doses of 1 ml each injected s.c. in the deltoid region at 4–6 week intervals. A fourth dose is given 6–12 months later. Booster doses are given every 5 years.
Side effects
Common
FeverLocal pain
Serious
- Allergic reactions (sometimes, probably due to animal protein in vaccine)
Related guidelines
Other Killed (Inactivated) viral vaccine drugs
Ask House about inactivated poliomyelitis vaccine
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team